ARTICLE | Finance

Passage to India

BB Biotech makes first investments in India: Glenmark, Lupin, Strides Arcolab

August 1, 2011 7:00 AM UTC

Lured by strong market growth prospects and diversified risk portfolios, BB Biotech AG pulled the trigger on its first investments in Indian biotechs last quarter. The three new portfolio companies - Glenmark Pharmaceuticals Ltd., Lupin Ltd. and Strides Arcolab Ltd. - each offer a different ratio of innovator to generic products.

In its 2Q report to shareholders last week, BB Biotech expressed confidence that the healthcare sector would perform well this half, and said it plans to continue reallocating assets from large cap to small and mid-cap biotechs...